Clinical Trial Update: 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a three-month finasteride challenge test suggests it can significantly improve the performance of prostate cancer screening.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2017-09-08